Aligned with
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
SDG 3 — Good Health and Well-being
SDG 4 — Quality Education
SDG 9 — Industry, Innovation and Infrastructure
SDG 10 — Reduced Inequalities
This track will explore the latest innovations in molecular diagnostics for lupus and related autoimmune disorders. Emphasis will be placed on the identification and validation of novel biomarkers that enhance diagnostic accuracy.
This session will focus on the bridge between laboratory discoveries and clinical applications in the field of autoimmune diseases. Presentations will highlight successful translational research initiatives that have led to improved patient outcomes.
This track will examine emerging therapeutic strategies and treatment modalities for managing lupus and its complications. Discussions will include both pharmacological and non-pharmacological approaches to patient care.
This session will delve into the underlying immunological mechanisms that drive lupus and other autoimmune conditions. Research findings will be presented that elucidate the role of immune dysregulation in disease pathogenesis.
This track will address innovative clinical research methodologies tailored for rheumatology studies. Emphasis will be placed on the design, implementation, and analysis of clinical trials in lupus and autoimmune disorders.
This session will focus on the importance of patient-centered approaches in the management of lupus and autoimmune diseases. Presentations will highlight strategies for enhancing patient engagement and improving quality of care.
This track will showcase cutting-edge laboratory techniques and technologies that are transforming the field of rheumatology. Topics will include advancements in diagnostic tools and research methodologies.
This session will explore the latest findings in biomarker discovery for lupus and related autoimmune disorders. Researchers will present their work on identifying potential biomarkers for disease diagnosis and monitoring.
This track will investigate the epidemiological aspects and risk factors associated with lupus and autoimmune disorders. Discussions will include population-based studies and their implications for public health.
This session will examine the psychosocial impact of lupus and autoimmune diseases on patients and their families. Research will focus on mental health, coping strategies, and support systems.
This track will provide insights into future research directions and emerging trends in the field of rheumatology. Participants will discuss potential breakthroughs and the implications for clinical practice.
SNRI maintains uninterrupted academic processes in the current global situation. Participants can engage and publish through online and blended conference formats.
PLEASE READ: CLOSING ENABLED IN 20S